Sofie Voet

Cross-species cellular mapping and humanization of Fc. receptors to advance antibody modeling

Karel Van Damme (UGent) , Dorine Sichien (UGent) , Katrien Van Der Borght (UGent) , Sofie Van Gassen (UGent) , Elisabeth De Leeuw (UGent) , Victor Bosteels, Joseph Jorssen, Seppe De Winter, Alan Korman, Fabio Benigni, et al.

(2025) ARTHRITIS & RHEUMATOLOGY. 77(Suppl. 9). p.1784-1786

Add to list

Cross-species cellular mapping and humanization of Fc receptors to advance antibody modeling

Karel Van Damme (UGent) , Dorine Sichien (UGent) , Katrien Van Der Borght (UGent) , J. Van Moorleghem, Elisabeth De Leeuw (UGent) , Dirk Elewaut (UGent) , Ariane Morel, Eric Vivier, Fabiane Sonego, Kader Thiam, et al.

(2025) ANNALS OF THE RHEUMATIC DISEASES. 84(Suppl. 1). p.1216-1217

Add to list

Journal Article
A1
open access

Inflammasome signaling is dispensable for ß-amyloid-induced neuropathology in preclinical models of Alzheimer's disease

Sahana Srinivasan, Daliya Kancheva, Sofie De Ren, Takashi Saito, Maude Jans (UGent) , Fleur Boone (UGent) , Charysse Vandendriessche (UGent) , Ine Paesmans, Herve Maurin, Roosmarijn Vandenbroucke (UGent) , et al.

(2024) FRONTIERS IN IMMUNOLOGY. 15.

Add to list

Journal Article
A1
open access

Two distinct ubiquitin-binding motifs in A20 mediate its anti-inflammatory and cell-protective activities

Arne Martens (UGent) , Dario Priem (UGent) , Esther Hoste (UGent) , Jessica Vetters (UGent) , Sofie Rennen (UGent) , Leen Catrysse (UGent) , Sofie Voet, Laura Deelen (UGent) , Mozes Sze (UGent) , Hanna-Kaisa Vikkula (UGent) , et al.

(2020) NATURE IMMUNOLOGY. 21(4). p.381-387

Add to list

Journal Article
A1
open access

OTULIN prevents liver inflammation and hepatocellular carcinoma by inhibiting FADD- and RIPK1 kinase-mediated hepatocyte apoptosis

Lien Verboom, Arne Martens (UGent) , Dario Priem (UGent) , Esther Hoste (UGent) , Mozes Sze (UGent) , Hanna-Kaisa Vikkula (UGent) , Lisette Van Hove, Sofie Voet, Jana Roels (UGent) , Jonathan Maelfait (UGent) , et al.

(2020) CELL REPORTS. 30(7). p.2237-2247

Add to list

Journal Article
A1
open access

Inflammasomes in neuroinflammatory and neurodegenerative diseases

Sofie Voet, Sahana Srinivasan, Mohamed Lamkanfi (UGent) and Geert van Loo (UGent)

(2019) EMBO MOLECULAR MEDICINE. 11(6).

Add to list

PhD Thesis

Study of inflammatory signaling and microglia activation in central nervous system pathology

Sofie Voet

(2019)

Add to list

Microglia in central nervous system inflammation and multiple sclerosis pathology

Sofie Voet, Marco Prinz and Geert van Loo (UGent)

(2019) TRENDS IN MOLECULAR MEDICINE. 25(2). p.112-123

Add to list

Journal Article
A1
open access

A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammation

Sofie Voet, Conor Mc Guire (UGent) , Nora Hagemeyer, Arne Martens (UGent) , Anna Schroeder, Peter Wieghofer, Carmen Daems, Ori Staszewski, Lieselotte Vande Walle (UGent) , Marta Joana Costa Jordao, et al.

(2018) NATURE COMMUNICATIONS. 9.

Add to list

S100B is a potential disease activity marker in nonsegmental vitiligo

Reinhart Speeckaert (UGent) , Sofie Voet, Esther Hoste (UGent) and Nanja van Geel (UGent)

(2017) JOURNAL OF INVESTIGATIVE DERMATOLOGY. 137(7). p.1445-1453

Academic Bibliography

Sofie Voet

Cross-species cellular mapping and humanization of Fc. receptors to advance antibody modeling

Cross-species cellular mapping and humanization of Fc receptors to advance antibody modeling

Inflammasome signaling is dispensable for ß-amyloid-induced neuropathology in preclinical models of Alzheimer's disease

Two distinct ubiquitin-binding motifs in A20 mediate its anti-inflammatory and cell-protective activities

OTULIN prevents liver inflammation and hepatocellular carcinoma by inhibiting FADD- and RIPK1 kinase-mediated hepatocyte apoptosis

Inflammasomes in neuroinflammatory and neurodegenerative diseases

Study of inflammatory signaling and microglia activation in central nervous system pathology

Microglia in central nervous system inflammation and multiple sclerosis pathology

A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammation

S100B is a potential disease activity marker in nonsegmental vitiligo

Contents

Support

Contact